Other
Puren Hospital Affiliated to Wuhan University of Science and Technology
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
Failure Rate
33.3%
1 terminated/withdrawn out of 3 trials
Success Rate
50.0%
-36.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
1(33.3%)
Phase 1
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Phase 1(1)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06265051Phase 2Completed
Tirofiban After Successful MT Recanalization in AIS
Role: collaborator
NCT04339660Phase 1Unknown
Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia
Role: lead
NCT04293692Not ApplicableWithdrawn
Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus
Role: lead
All 3 trials loaded